Table 2.
Summary of study patient characteristics
| Number | 90 (91 targets) |
| Sex | |
| Male | 38 |
| Female | 52 |
| Age median | 75 (50–92) |
| Stage | T1-T4 |
| Tumour location | |
| RUL | 27 |
| RML | 6 |
| RLL | 15 |
| LUL | 33 |
| LLL | 9 |
| LH | 1 |
| Target volume | |
| GTV | Median 5.5 cm3 (0.2–133.3) |
| PTV | Median 31.8 cm3 (5.1–252.5) |
| Dose/fractionation | |
| 20 Gy × 3 | 8 |
| 18 Gy × 3 | 31 |
| 10 Gy × 5 | 49 |
| Miscellaneous | 3 |
| Treatment technique | VMAT |
GTV, gross tumour volume; LH, left hilum; LLL, left lower lobe; LUL, left upper lobe; PTV, planning target volume; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; VMAT, volumetric modulated arc therapy.